Tag Archives: Bob Miller

On the ‘Gom-Boo,’ Ampligen, and Holding Out Hope

About a week ago, my obituary arrived by email. But something related, which you might think is weirder, happened Tuesday afternoon, and all of it involves chronic fatigue syndrome (CFS), and Hemispherx Biopharma Inc.’s drug candidate for it, Ampligen. More…